|
1
|
Siegel RL, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Holmes RS and Vaughan TL: Epidemiology and
pathogenesis of esophageal cancer. Semin Radiat Oncol. 17:2–9.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Enzinger PC and Mayer RJ: Esophageal
cancer. N Engl J Med. 349:2241–2252. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hu D, Zhang M, Wang S and Wang Z: High
expression of cyclooxygenase 2 is an indicator of prognosis for
patients with esophageal squamous cell carcinoma after Ivor Lewis
esophagectomy. Thorac Cancer. 7:310–315. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Qin HD, Liao XY, Chen YB, Huang SY, Xue
WQ, Li FF, Ge XS, Liu DQ, Cai Q, Long J, et al: Genomic
characterization of esophageal squamous cell carcinoma reveals
critical genes underlying tumorigenesis and poor prognosis. Am J
Hum Genet. 98:709–727. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gibb EA, Brown CJ and Wan LL: The
functional role of long non-coding RNA in human carcinomas. Mol
Cancer. 10:382011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cheetham SW, Gruhl F, Mattick JS and
Dinger ME: Long noncoding RNAs and the genetics of cancer. Br J
Cancer. 108:2419–2425. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yao J, Huang JX, Lin M, Wu ZD, Yu H, Wang
PC, Ye J, Chen P, Wu J and Zhao GJ: Microarray expression profile
analysis of aberrant long non-coding RNAs in esophageal squamous
cell carcinoma. Int J Oncol. 48:2543–2557. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen X, Kong J, Ma Z, Gao S and Feng X: Up
regulation of the long non-coding RNA NEAT1 promotes esophageal
squamous cell carcinoma cell progression and correlates with poor
prognosis. Am J Cancer Res. 5:2808–2815. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tan D, Wu Y, Hu L, He P, Xiong G, Bai Y
and Yang K: Long noncoding RNA H19 is up-regulated in esophageal
squamous cell carcinoma and promotes cell proliferation and
metastasis. Dis Esophagus. 30:1–9. 2017.
|
|
11
|
Zang W, Wang T, Wang Y, Chen X, Du Y, Sun
Q, Li M, Dong Z and Zhao G: Knockdown of long non-coding RNA
TP73-AS1 inhibits cell proliferation and induces apoptosis in
esophageal squamous cell carcinoma. Oncotarget. 7:19960–19974.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schneider C, King RM and Philipson L:
Genes specifically expressed at growth arrest of mammalian cells.
Cell. 54:787–793. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Smith CM and Steitz JA: Classification of
gas5 as a multi-small-nucleolar-RNA (snoRNA) host gene and a member
of the 5′-terminal oligopyrimidine gene family reveals common
features of snoRNA host genes. Mol Cell Biol. 18:6897–6909. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pickard MR, Mourtada-Maarabouni M and
Williams GT: Long non-coding RNA GAS5 regulates apoptosis in
prostate cancer cell lines. Biochim Biophys Acta. 1832:1613–1623.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chang L, Li C, Lan T, Wu L, Yuan Y, Liu Q
and Liu Z: Decreased expression of long non-coding RNA GAS5
indicates a poor prognosis and promotes cell proliferation and
invasion in hepatocellular carcinoma by regulating vimentin. Mol
Med Rep. 13:1541–1550. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shi X, Sun M, Liu H, Yao Y, Kong R, Chen F
and Song Y: A critical role for the long non-coding RNA GAS5 in
proliferation and apoptosis in non-small-cell lung cancer. Mol
Carcinog. 54 Suppl 1:E1–E12. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mourtada-Maarabouni M, Pickard MR, Hedge
VL, Farzaneh F and Williams GT: GAS5, a non-protein-coding RNA,
controls apoptosis and is downregulated in breast cancer. Oncogene.
28:195–208. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Qiao HP, Gao WS, Huo JX and Yang ZS: Long
non-coding RNA GAS5 functions as a tumor suppressor in renal cell
carcinoma. Asian Pac J Cancer Prev. 14:1077–1082. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
García-Claver A, Lorente M, Mur P,
Campos-Martín Y, Mollejo M, Velasco G and Meléndez B: Gene
expression changes associated with erlotinib response in glioma
cell lines. Eur J Cancer. 49:1641–1653. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen T, Stephens PA, Middleton FK and
Curtin NJ: Targeting the S and G2 checkpoint to treat cancer. Drug
Discov Today. 17:194–202. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Squatrito M, Brennan CW, Helmy K, Huse JT,
Petrini JH and Holland EC: Loss of ATM/Chk2/p53 pathway components
accelerates tumor development and contributes to radiation
resistance in gliomas. Cancer Cell. 18:619–629. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim S, Lee HS, Ji JH, Cho MY, Yoo YS, Park
YY, Cha HJ, Lee Y, Kim Y and Cho H: Hepatitis B virus X protein
activates the ATM-Chk2 pathway and delays the cell cycle
progression. J Gen Virol. 96:2242–2251. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhu H, Miao ZH, Huang M, Feng JM, Zhang
ZX, Lu JJ, Cai YJ, Tong LJ, Xu YF, Qian XH and Ding J:
Naphthalimides induce G(2) arrest through the ATM-activated
Chk2-executed pathway in HCT116 cells. Neoplasia. 11:1226–1234.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gaul L, Mandl-Weber S, Baumann P, Emmerich
B and Schmidmaier R: Bendamustine induces G2 cell cycle arrest and
apoptosis in myeloma cells: The role of ATM-Chk2-Cdc25A and
ATM-p53-p21-pathways. J Cancer Res Clin Oncol. 134:245–253. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang R, Zhu L, Zhang L, Xu A, Li Z, Xu Y,
He P, Wu M, Wei F and Wang C: PTEN enhances G2/M arrest in
etoposide-treated MCF-7 cells through activation of the ATM
pathway. Oncol Rep. 35:2707–2714. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: At the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Thompson EW, Newgreen DF and Tarin D:
Carcinoma invasion and metastasis: A role for
epithelial-mesenchymal transition? Cancer Res. 65:5991–5995. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ju JY, Yu WJ and Zhao CL: PLK1 promotes
invasion of esophageal squamous cell carcinoma cells through
inducing epithelial-mesenchymal transition. Adv Mater Res.
998-999:279–282. 2014. View Article : Google Scholar
|
|
30
|
Ping FM, Liu GJ, Liu ZJ, Li HB, Zhai JW,
Li SX, Liu YM, Li BW and Wei H: Expression of RKIP, E-cadherin and
NF-kB p65 in esophageal squamous cell carcinoma and their
correlations. Int J Clin Exp Pathol. 8:10164–10170. 2014.
|
|
31
|
Ma B, Zhang HY, Bai X, Wang F, Ren XH,
Zhang L and Zhang MZ: ADAM10 mediates the cell invasion and
metastasis of human esophageal squamous cell carcinoma via
regulation of E-cadherin activity. Oncol Rep. 35:2785–2794. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Natsugoe S, Uchikado Y, Okumura H,
Matsumoto M, Setoyama T, Tamotsu K, Kita Y, Sakamoto A, Owaki T,
Ishigami S and Aikou T: Snail plays a key role in
E-cadherin-preserved esophageal squamous cell carcinoma. Oncol Rep.
17:517–523. 2007.PubMed/NCBI
|
|
33
|
Li K, He W, Lin N, Wang X and Fan QX:
N-cadherin knock-down decreases invasiveness of esophageal squamous
cell carcinoma in vitro. World J Gastroenterol. 15:697–704. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang F, Li XK, Xu HY, Shan ZZ, Wang T,
Yang ZC, He W, Wang LX and Fan QX: N-cadherin participated in
invasion and metastasis of human esophageal squamous cell carcinoma
via taking part in the formation of vasculogenic mimicry. Med
Oncol. 32:4802015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jin H, Morohashi S, Sato F, Kudo Y,
Akasaka H, Tsutsumi S, Ogasawara H, Miyamoto K, Wajima N, Kawasaki
H, et al: Vimentin expression of esophageal squamous cell carcinoma
and its aggressive potential for lymph node metastasis. Biomed Res.
31:105–112. 2010. View Article : Google Scholar : PubMed/NCBI
|
